作者: Rhonda K. Yantiss , Wade S. Samowitz
DOI: 10.1016/J.PATH.2012.08.002
关键词:
摘要: The purpose of this review is to discuss important molecular changes that aid decision making in patient management and play a role emerging treatment strategies for gastrointestinal malignancies. Although screening surveillance practices have had an impact on the natural history some tumor types, gastric carcinoma major cause morbidity mortality high prevalence regions colorectal still fourth leading cancer related death United States.